Invention Grant
- Patent Title: Amidine substituted analogues and uses thereof
-
Application No.: US16470922Application Date: 2017-12-21
-
Publication No.: US11098009B2Publication Date: 2021-08-24
- Inventor: François Ravenelle , Michel Therien , Helmi Zaghdane
- Applicant: Verlyx Pharma Inc.
- Applicant Address: CA Pointe-Claire
- Assignee: Verlyx Pharma Inc.
- Current Assignee: Verlyx Pharma Inc.
- Current Assignee Address: CA Pointe-Claire
- Agency: Bozicevic, Field & Francis LLP
- Agent Edward J. Baba
- International Application: PCT/CA2017/051576 WO 20171221
- International Announcement: WO2018/112649 WO 20180628
- Main IPC: A61P37/00
- IPC: A61P37/00 ; A61P37/06 ; C07C257/18
Abstract:
The present application relates to amidine substituted analogues as shown in formula I and uses thereof as an anti-inflammatory agent and/or for the treatment of an immunological disorder or of an inflammatory bowel disease including ulcerative colitis, Crohn's diseases, collagenous colitis and lymphocytic colitis.
Public/Granted literature
- US20200087252A1 AMIDINE SUBSTITUTED ANALOGUES AND USES THEREOF Public/Granted day:2020-03-19
Information query
